Hearing loss can stem from both genetic and non-genetic factors. Genetics contributes to a significant portion of congenital hearing loss in babies. As people age, they may experience a gradual ...
Scientists have identified mutations in the CPD gene as a key cause of a rare congenital hearing loss, revealing how disruptions in arginine and nitric oxide signaling damage sensory cells in the ear.
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...
Researchers have understood for decades that some forms of deafness are inherited, yet until now, few of those genetic clues have led the way to therapy. That is beginning to change. An international ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have ...
The three types of hearing loss are sensorineural, conductive, and mixed hearing loss. They each involve different parts of the ear and may have varying causes and treatments. Hearing loss in one or ...
In a small pivotal trial of an investigational gene therapy, most cases of congenital profound deafness from genetic variants in OTOF showed hearing improvement. Three-fourths of those treated ...
Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results